norstella-logo-white

Resources

Toggle Filters
White paper icon
White paper

Innovation trends from R&D to...

2024 has been an incredibly busy year for Norstella as its constituent organizations – Citeline, Evaluate, MMIT, Panalgo, and the Dedham Group – have continued to support the biopharma ecosystem in bringing new therapies to patients....
Download the white paper
Report icon
Report

Assessing AI transformation in pharma...

Artificial intelligence (AI) has been one of the largest disruptors in drug development over the past few years, with the promise of innovation and greater efficiencies keeping the pharma industry heavily invested. There have been major...
Download the report
Article icon
Article

Harnessing lab data to speed...

In recent years, pharma companies have begun to embrace lab data as a richly rewarding dataset for a whole host of purposes, including trial enrollment and site identification, patient monitoring and disease progression, and commercial targeting...
Read the article
Podcast icon
Podcast

Conference catch-up: Collaboration and innovation...

The biopharma industry is evolving, with increased focus on partnerships, early-phase deal-making and technologies like AI and machine learning. At this year’s BIO-Europe conference in Stockholm, Norstella’s subject matter experts joined discussions on key topics, including...
Listen to the podcast
Article icon
Article

Spotlight on China: A dominant...

In a series exploring trends across the APAC region, Norstella’s subject matter experts from key biopharma hubs delve into this year’s standout developments and share their outlook for 2025. China’s booming clinical trial landscape continues to...
Read the article
category
Video

Level up your lab data:... Level up your lab data: New use cases for improving time to treatment

Real-world data is essential to gaining insights into a patient’s diagnostic journey, but many pharma...
Watch the video
category
Podcast

Conference catch-up: Navigating the evolving... Conference catch-up: Navigating the evolving CDMO landscape

Contract development and manufacturing organizations (CDMOs) are reshaping pharmaceutical production, playing a pivotal role in...
View resource
category
Article

Assessing current AI trends in... Assessing current AI trends in drug development: Adoption and transformation (part 1)

Pharmaceutical R&D is undergoing significant changes. The need to accelerate drug development and enhance decision-making...
View resource
category
Podcast

Conference catch-up: The rise of... Conference catch-up: The rise of digital therapeutics (part 2)

Health technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving...
View resource
category
Infographic

The current & future impact... The current & future impact of AI on pharmaceutical R&D

Artificial intelligence (AI) continues to disrupt existing paradigms in drug development, with early adopters experiencing...
View resource
category
In the news

Norstella rolls out NorstellaLinQ data... Norstella rolls out NorstellaLinQ data platform

Norstella LinQ establishes a throughline between the company’s various subsidiaries, utilizing capabilities from Citeline, Evaluate,...
View resource
category
Article

The practice-changing drugs that will... The practice-changing drugs that will land in 2025

2025 promises to represent another rich year of progress. A wealth of new therapies are...
View resource
category
Podcast

Conference catch-up: The rise of... Conference catch-up: The rise of digital therapeutics (part 1)

Healthcare technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving...
View resource
category
Article

Pharma’s future: More with less Pharma’s future: More with less

2023 saw the biopharmaceutical industry spend a record $300bn on R&D activities, reinvesting approximately 30%...
View resource
category
Video

Redefining patient access strategy Redefining patient access strategy

Patient access continues to be a major hurdle in the US pharma industry, impacting the...
Watch the video
category
Ebook

The next wave in oncology:... The next wave in oncology: 7 innovations redefining cancer treatment in 2024 and beyond

Oncology is undergoing a transformative shift, with new therapies and technologies driving significant improvements in...
View resource
category
Article

Pharma outlook: From uncertainty to... Pharma outlook: From uncertainty to predictability

Change is the only constant in the pharmaceuticals industry. There have been many paradigm shifts...
View resource